Amanda Johns

2.0k total citations
28 papers, 1.6k citations indexed

About

Amanda Johns is a scholar working on Endocrine and Autonomic Systems, Cognitive Neuroscience and Experimental and Cognitive Psychology. According to data from OpenAlex, Amanda Johns has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrine and Autonomic Systems, 11 papers in Cognitive Neuroscience and 10 papers in Experimental and Cognitive Psychology. Recurrent topics in Amanda Johns's work include Sleep and Wakefulness Research (11 papers), Sleep and related disorders (10 papers) and Regulation of Appetite and Obesity (10 papers). Amanda Johns is often cited by papers focused on Sleep and Wakefulness Research (11 papers), Sleep and related disorders (10 papers) and Regulation of Appetite and Obesity (10 papers). Amanda Johns collaborates with scholars based in United Kingdom, United States and Australia. Amanda Johns's co-authors include Rod A. Porter, Jonathan R.S. Arch, N. Upton, Roderick A. Porter, Stephen Brough, Frances Jewitt, Jeffrey C. Jerman, John A. Murphy, R.J. Rodgers and John E. Blundell and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Pain.

In The Last Decade

Amanda Johns

27 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amanda Johns United Kingdom 16 1.2k 1.2k 848 166 147 28 1.6k
Rod A. Porter United Kingdom 16 949 0.8× 900 0.8× 645 0.8× 279 1.7× 86 0.6× 25 1.6k
Kazuki Honda Japan 18 793 0.6× 655 0.5× 498 0.6× 170 1.0× 39 0.3× 35 1.1k
Koki Kato Japan 17 227 0.2× 430 0.4× 159 0.2× 286 1.7× 137 0.9× 30 1.1k
Tonya C. Murphy United States 17 249 0.2× 408 0.3× 170 0.2× 655 3.9× 46 0.3× 23 1.3k
Spencer J. Tye United Kingdom 19 402 0.3× 211 0.2× 215 0.3× 437 2.6× 41 0.3× 26 913
Catherine Roch Switzerland 16 286 0.2× 214 0.2× 221 0.3× 315 1.9× 96 0.7× 30 837
K. Fukatsu Japan 11 172 0.1× 279 0.2× 153 0.2× 73 0.4× 241 1.6× 18 749
Haruhide Kimura Japan 22 307 0.3× 208 0.2× 210 0.2× 309 1.9× 76 0.5× 81 1.3k
Anupama Gopalakrishnan United States 5 178 0.1× 124 0.1× 98 0.1× 160 1.0× 41 0.3× 6 531
Michelle Baladi United States 16 215 0.2× 286 0.2× 131 0.2× 349 2.1× 10 0.1× 40 784

Countries citing papers authored by Amanda Johns

Since Specialization
Citations

This map shows the geographic impact of Amanda Johns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amanda Johns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amanda Johns more than expected).

Fields of papers citing papers by Amanda Johns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amanda Johns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amanda Johns. The network helps show where Amanda Johns may publish in the future.

Co-authorship network of co-authors of Amanda Johns

This figure shows the co-authorship network connecting the top 25 collaborators of Amanda Johns. A scholar is included among the top collaborators of Amanda Johns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amanda Johns. Amanda Johns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Porter, Roderick A., Amanda Johns, D. Nash, et al.. (2011). Acylglycinamides as inhibitors of glycine transporter type 1. Bioorganic & Medicinal Chemistry Letters. 21(20). 6176–6179. 1 indexed citations
2.
Tran, Khoa D., et al.. (2008). Acute hyperammonemic encephalopathy in adult onset ornithine transcarbamylase deficiency. Intensive Care Medicine. 34(10). 1922–1924. 29 indexed citations
3.
Schwartzberg, Lee S., Clinton F. Stewart, Paula Schaiquevich, et al.. (2008). Phase I dosage-finding and pharmacokinetic (PK) study of intravenous topotecan and oral erlotinib in patients (pts) with refractory solid tumors. Journal of Clinical Oncology. 26(15_suppl). 2549–2549. 1 indexed citations
4.
Ishii, Yasuyuki, John E. Blundell, Jason C. G. Halford, et al.. (2004). Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats. Physiology & Behavior. 81(1). 129–140. 55 indexed citations
5.
Ishii, Yasuyuki, John E. Blundell, Jason C. G. Halford, et al.. (2004). Anorexia and weight loss in male rats 24h following single dose treatment with orexin-1 receptor antagonist SB-334867. Behavioural Brain Research. 157(2). 331–341. 55 indexed citations
6.
Ishii, Yasuyuki, John E. Blundell, Jason C. G. Halford, et al.. (2004). Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S. Behavioural Brain Research. 160(1). 11–24. 35 indexed citations
7.
Rodgers, R.J., Jason C. G. Halford, D.C Piper, et al.. (2001). SB‐334867, a selective orexin‐1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin‐A in rats. European Journal of Neuroscience. 13(7). 1444–1452. 196 indexed citations
8.
Jones, Declan N.C., Jane Gartlon, Frederick B. Parker, et al.. (2001). Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity. Psychopharmacology. 153(2). 210–218. 78 indexed citations
9.
Duxon, Mark, Kathryn R. Starr, Declan N.C. Jones, et al.. (2001). Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement. Psychopharmacology. 153(2). 203–209. 79 indexed citations
10.
Porter, Roderick A., Wai N. Chan, Steven Coulton, et al.. (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters. 11(14). 1907–1910. 119 indexed citations
11.
Bingham, Sharon, Philip T. Davey, Elaine Irving, et al.. (2001). Orexin-A, an hypothalamic peptide with analgesic properties. Pain. 92(1). 81–90. 234 indexed citations
12.
Bingham, Sharon, Philip T. Davey, Elaine Irving, et al.. (2001). Orexin‐A, an hypothalamic peptide with analgesic properties. (SmithKline Beecham Pharmaceuticals, Harlow, Essex, United Kingdom) Pain. 2001;92:81–90.. Pain Practice. 1(4). 375–375. 1 indexed citations
13.
Haynes, Andrea, Brian A. Jackson, Helen Chapman, et al.. (2000). A selective orexin-1 receptor antagonist reduces food consumption in male and female rats. Regulatory Peptides. 96(1-2). 45–51. 263 indexed citations
14.
Boyfield, Izzy, Martyn C. Coldwell, Michael S. Hadley, et al.. (1997). 2-[(substituted)phenyl]-5-[1-(2-phenylazacycloheptyl)methyl]-1H-pyrroles with high affinity and selectivity for the dopamine D3 receptor. Bioorganic & Medicinal Chemistry Letters. 7(4). 485–488. 9 indexed citations
15.
Boyfield, Izzy, Martyn C. Coldwell, Michael S. Hadley, et al.. (1996). N-(substituted-phenyl) piperazines: antagonists with high binding and functional selectivity for dopamine D4 receptors. Bioorganic & Medicinal Chemistry Letters. 6(11). 1227–1232. 14 indexed citations
16.
Greenberg, Stanley S., Amanda Johns, Joseph F. Kleha, et al.. (1994). Phenol red is a thromboxane A2/prostaglandin H2 receptor antagonist in canine lingual arteries and human platelets.. Journal of Pharmacology and Experimental Therapeutics. 268(3). 1352–1361. 7 indexed citations
17.
Johns, Amanda, et al.. (1993). The Synthesis of 4-Amino-2-methyl-3-(1-oxo) Pent-4-ynyl-5,6,7,8-tetrahydrobenzo[b]thieno[2,3-b]pyridine. Synthetic Communications. 23(19). 2683–2689.
18.
Begley, Michael J., et al.. (1991). Intramolecular reactions of allyloxy radicals featuring six-centred transition states; Regiochemistry and stereochemistry.. Tetrahedron. 47(39). 8417–8430. 5 indexed citations
19.
Johns, Amanda & John A. Murphy. (1988). Cyclisations of allyloxy radicals. Tetrahedron Letters. 29(7). 837–840. 52 indexed citations
20.
Johns, Amanda, et al.. (1987). A novel probe for free-radical intermediates. Journal of the Chemical Society Chemical Communications. 1238–1238. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rod A. Porter Breakdown of academic impact, for papers by Kazuki Honda Breakdown of academic impact, for papers by Koki Kato Breakdown of academic impact, for papers by Tonya C. Murphy Breakdown of academic impact, for papers by Spencer J. Tye Breakdown of academic impact, for papers by Catherine Roch Breakdown of academic impact, for papers by K. Fukatsu Breakdown of academic impact, for papers by Haruhide Kimura Breakdown of academic impact, for papers by Anupama Gopalakrishnan Breakdown of academic impact, for papers by Michelle Baladi
Rankless by CCL
2026